A life sciences or medical product company is yet to make it big anywhere in India, despite a startup culture that is 15 years old.

Proceeds from the Series B round of funding will be used to drive the completion of critical milestones of US Food and Drug Administration ...

Lifesciences startups in India are no longer risk averse, developing applications like fuel from seaweed and nanomedicine that shrinks tumo...

Spanning areas such as medical devices, stem cells and next generation drugs, a group of startups is creating breakthrough innovations that...

Vyome Biosciences has raised Rs 18.50 crore in its Series A round of funding, led by venture capital firm, IndoUS Venture Partners, with pa...

Global scientists of Indian-origin, who have made path-breaking discoveries in the field of healthcare, are moving to India to test, valida...